Dent Neurologic

716-250-2000

Menu
Menu

Alzheimer’s Study

IGC Pharma CALMA

Alzheimer's, Research Study / By

IGC Pharma CALMA (Alzheimer’s Disease with Agitation) This is a trial of the safety and efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease Inclusion Criteria: 60 years of age and above Diagnosis of probable Alzheimer’s Disease Clinically significant agitation, must have a caregiver who can comply with required procedures What

IGC Pharma CALMA Read More »

ADNI4 Trial

Active, No Longer Recruiting, Alzheimer's, Research Study, Uncategorized / By

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, non-treatment study. 1,150 participants will be enrolled across three cohorts: cognitively normal (CN), mild cognitive impairment (MCI) and dementia (DEM). Participants between the ages of 55-90 (inclusive) will be enrolled at 59 sites in the United States and Canada. Approximately, 750 participants will be newly

ADNI4 Trial Read More »

Scroll to Top